N-[(4-methylpiperazin-1-yl)methyl]-N'-[(1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-piperidine]-16-yl]propanediamide

C36H61N5O3 — CID 176806681

IUPACN-[(4-methylpiperazin-1-yl)methyl]-N'-[(1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-piperidine]-16-yl]propanediamide
SMILESC[C@@H]1CC[C@@]2(NC1)O[C@H]1C[C@H]3[C@@H]4CC[C@H]5C[C@@H](NC(=O)CC(=O)NCN6CCN(C)CC6)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C
InChIInChI=1S/C36H61N5O3/c1-23-8-13-36(38-21-23)24(2)33-30(44-36)19-29-27-7-6-25-18-26(9-11-34(25,3)28(27)10-12-35(29,33)4)39-32(43)20-31(42)37-22-41-16-14-40(5)15-17-41/h23-30,33,38H,6-22H2,1-5H3,(H,37,42)(H,39,43)/t23-,24+,25+,26+,27-,28+,29+,30+,33+,34+,35+,36-/m1/s1
InChIKeyQGMVDWSMGIDRAR-YJHTXLRQSA-N
MW611.92 g/mol
LogP4.20
Rot. Bonds5

About N-[(4-methylpiperazin-1-yl)methyl]-N'-[(1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-piperidine]-16-yl]propanediamide

N-[(4-methylpiperazin-1-yl)methyl]-N'-[(1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-piperidine]-16-yl]propanediamide (PubChem CID 176806681) has the molecular formula C36H61N5O3 and a molecular weight of 611.92 g/mol. Its IUPAC name is N-[(4-methylpiperazin-1-yl)methyl]-N'-[(1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-piperidine]-16-yl]propanediamide.

Molecular Properties

Compound NameN-[(4-methylpiperazin-1-yl)methyl]-N'-[(1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-piperidine]-16-yl]propanediamide
PubChem CID176806681
Molecular FormulaC36H61N5O3
Molecular Weight611.92 g/mol
Exact Mass611.48
IUPAC NameN-[(4-methylpiperazin-1-yl)methyl]-N'-[(1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-piperidine]-16-yl]propanediamide
SMILESC[C@@H]1CC[C@@]2(NC1)O[C@H]1C[C@H]3[C@@H]4CC[C@H]5C[C@@H](NC(=O)CC(=O)NCN6CCN(C)CC6)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C
InChIInChI=1S/C36H61N5O3/c1-23-8-13-36(38-21-23)24(2)33-30(44-36)19-29-27-7-6-25-18-26(9-11-34(25,3)28(27)10-12-35(29,33)4)39-32(43)20-31(42)37-22-41-16-14-40(5)15-17-41/h23-30,33,38H,6-22H2,1-5H3,(H,37,42)(H,39,43)/t23-,24+,25+,26+,27-,28+,29+,30+,33+,34+,35+,36-/m1/s1
InChIKeyQGMVDWSMGIDRAR-YJHTXLRQSA-N
XLogP4.20
TPSA85.94 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds5
Heavy Atoms44
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500611.92
LogP ≤ 54.20
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Analyze N-[(4-methylpiperazin-1-yl)methyl]-N'-[(1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-piperidine]-16-yl]propanediamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(4-methylpiperazin-1-yl)methyl]-N'-[(1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-piperidine]-16-yl]propanediamide?
The IUPAC name of N-[(4-methylpiperazin-1-yl)methyl]-N'-[(1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-piperidine]-16-yl]propanediamide (CID 176806681) is N-[(4-methylpiperazin-1-yl)methyl]-N'-[(1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-piperidine]-16-yl]propanediamide.
What is the SMILES notation for N-[(4-methylpiperazin-1-yl)methyl]-N'-[(1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-piperidine]-16-yl]propanediamide?
The canonical SMILES for N-[(4-methylpiperazin-1-yl)methyl]-N'-[(1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-piperidine]-16-yl]propanediamide is C[C@@H]1CC[C@@]2(NC1)O[C@H]1C[C@H]3[C@@H]4CC[C@H]5C[C@@H](NC(=O)CC(=O)NCN6CCN(C)CC6)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C.
What is the InChIKey of N-[(4-methylpiperazin-1-yl)methyl]-N'-[(1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-piperidine]-16-yl]propanediamide?
The InChIKey is QGMVDWSMGIDRAR-YJHTXLRQSA-N. The full InChI is InChI=1S/C36H61N5O3/c1-23-8-13-36(38-21-23)24(2)33-30(44-36)19-29-27-7-6-25-18-26(9-11-34(25,3)28(27)10-12-35(29,33)4)39-32(43)20-31(42)37-22-41-16-14-40(5)15-17-41/h23-30,33,38H,6-22H2,1-5H3,(H,37,42)(H,39,43)/t23-,24+,25+,26+,27-,28+,29+,30+,33+,34+,35+,36-/m1/s1.
What are the key properties of N-[(4-methylpiperazin-1-yl)methyl]-N'-[(1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-piperidine]-16-yl]propanediamide?
N-[(4-methylpiperazin-1-yl)methyl]-N'-[(1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-piperidine]-16-yl]propanediamide has a molecular weight of 611.92 g/mol, XLogP of 4.20, 5 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(4-methylpiperazin-1-yl)methyl]-N'-[(1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-piperidine]-16-yl]propanediamide is sourced from PubChem (CID 176806681), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).